FinnCap Reiterates Corporate Rating for Premaitha Health (NIPT)
Premaitha Health (LON:NIPT) opened at GBX 5.38 ($0.07) on Monday. Premaitha Health has a 12-month low of GBX 4.05 ($0.05) and a 12-month high of GBX 14.40 ($0.19).
About Premaitha Health
Premaitha Health PLC is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company’s product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house.
Receive News & Ratings for Premaitha Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premaitha Health and related companies with MarketBeat.com's FREE daily email newsletter.